Find Funding Opportunities

Find Funding Opportunities

Subscribe to Find Funding OpportunitiesRSS
Returning 1406 results

Notice of Special Interest (NOSI): Administrative Supplements to Support Collaborations to Improve the AI/ML-Readiness of NIH-Supported Data

Notice of Special Interest
Friday, April 16, 2021
Thursday, May 27, 2021
333
NOT-OD-21-094

Funding Opportunity Purpose

This Notice announces the availability of supplements to active grants which are intended to support collaborations that bring together expertise in biomedicine, data management, and artificial intelligence and machine learning (AI/ML) to make NIH-supported data useful and usable for AI/ML analytics. This initiative is aligned with the NIH Strategic Plan for Data Science, which describes actions aimed at modernizing the biomedical research data ecosystem and making data FAIR (Findable, Accessible, Interoperable, and Reusable) with high impact for open science. For the purposes of this Notice, AI/ML is inclusive of machine learning (ML), deep learning (DL), and neural networks (NN).

Notice of Change: Receipt date added for RFA-EB-20-002, "BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)

NOT
Wednesday, April 14, 2021
Wednesday, September 15, 2021
NOT-EB-21-006

Funding Opportunity Purpose

The purpose of this Notice is to inform interested applicants that the expiration date in PAR-18-205 " NIBIB Biomedical Technology Resource Centers (P41 Clinical Trials Optional)" will be extended by one receipt cycle (See changes in bold italics below). Part 1. Overview Key Dates Currently Reads: Expiration Date January 8, 2021 Modified to Read: Expiration Date May 8, 2021 All other aspects of this FOA remain unchanged.

Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations RADx-UP Phase II (Emergency Supplement - Clinical Trial Optional)

Notice of Special Interest
Tuesday, April 13, 2021
Tuesday, May 25, 2021
U01
NOT-OD-21-103

Funding Opportunity Purpose

This funding opportunity announcement (FOA) seeks competitive revisions for existing awards to support Phase II of the Rapid Acceleration of Diagnostics Underserved Populations (RADx-UP) initiative. These testing research projects will (1) expand the scope and reach of RADx-UP testing interventions to reduce COVID-19 disparities among underserved and vulnerable populations and (2) address scientific questions on interventions to increase access and uptake of COVID-19 testing given the increasing availability of SARS-CoV-2 vaccines. The funding for this initiative is provided from the American Rescue Plan Act of 2021.

Request for Information (RFI): Research Challenges and Needs in Developing Chronomedicine for Health and Diseases

NOT
Tuesday, April 13, 2021
Monday, January 1, 2024
NOT-CA-21-042

Funding Opportunity Purpose

The purpose of this Request for Information (RFI) is to gain feedback, comments, and novel ideas from the members of scientific communities in the United States (U.S.) and abroad as well as from persons representing other segments of American public to help identify the needs and priorities in this area of science, and plan future activities and initiatives that can most significantly enhance the research in chronotherapy, circadian-based medicine or chronomedicine and greater benefit of the biomedical research community.

Notice of Special Interest (NOSI): Administrative Supplements for Workforce Development at the Interface of Information Sciences, Artificial Intelligence and Machine Learning (AI/ML), and Biomedical Sciences

Notice of Special Interest
Monday, April 12, 2021
Saturday, May 15, 2021
333
NOT-OD-21-079

Funding Opportunity Purpose

The NIH Office of Data Science Strategy announces the availability of funds for Administrative Supplements to institutions with NIGMS-funded training (T32, T34), institutional career development (K12), or certain research education program (R25, see eligibility below) awards. The funds will support the development and implementation of curricular or training activities at the interface of information science, artificial intelligence and machine learning (AI/ML), and biomedical sciences to develop the competencies and skills needed to make biomedical data FAIR (Findable, Accessible, Interoperable, and Reusable) and AI/ML-ready. For the purposes of this Notice, AI/ML is inclusive of machine learning (ML), deep learning (DL), and neural networks (NN). See https://www.go-fair.org/fair-principles/ for a fuller description of FAIR principles.

HEAL Initiative: Notice of Special Interest (NOSI): Limited Competition to Support Mentorship of Junior Investigators

Notice of Special Interest
Friday, April 9, 2021
Sunday, June 13, 2021
K24
NOT-NS-21-026

Funding Opportunity Purpose

This Notice of Special Interest (NOSI) provides an opportunity for researchers funded by the Helping to End Addiction Long-Term (HEAL) initiative to devote more time for mentorship activities. The NIH defines a mentor as experienced scientist who can help guide the research of junior investigators and challenge them to develop independence as researchers. The objectives of mentoring include to enhancing a mentees approach to scientific investigation, developing their critical thinking and communication skills and assisting with their progression the research community. Mentoring responsibilities involve helping junior investigators defining research goals, supporting the achievement of those goals, and discussing and evaluating progress throughout training. A mentor should provide constructive and timely feedback, support training, networking and professional development opportunities, and acknowledge a mentees contribution to research. The award is intended to provide protected time for established investigators supported by the HEAL Initiative to simultaneously provide mentoring to junior investigators. The supplement is intended for investigators (principal investigators or co-investigators) who have a record of supervising and mentoring clinical pain researchers. The NIH HEAL Initiative is a trans-agency effort to speed scientific solutions to stem the national opioid public health crisis through understanding, managing, and treating pain and improving treatment for opioid use disorder and overdose.

Change to NINDS Administrative Reduction Policy for Modular R01 Awards

NOT
Monday, April 5, 2021
Monday, January 1, 2024
NOT-NS-21-053

Funding Opportunity Purpose

This NOTICE is to alert the extramural community that, as of the September 2020 NANDS Council round, NINDS will no longer apply administrative reductions to modular investigator-initiated R01 grants. However, non-modular R01 awards will continue to receive a 17.5% administrative reduction applied to IRG and NANDS Council budget recommendations (see: NINDS Funding Strategy). Investigators and recipient organizations should carefully consider this NIH guidance when developing budgets for R01 submissions (see Develop Your Budget). In accordance with the NIA Funding Strategy for AD/ADRD research, NINDS will continue to award the level of support recommended by the study section for applications funded through the Alzheimer's allocation, with adjustments deemed appropriate by NIH staff.

NIH Blueprint for Neuroscience Research: Request for Information (RFI) on Neuroimmune Interactions in the Healthy CNS

NOT
Monday, April 5, 2021
Monday, January 1, 2024
NOT-AA-21-012

Funding Opportunity Purpose

The National Institutes of Health Blueprint for Neuroscience Research (Blueprint) is a collaboration among 14 participating NIH Institutes, Centers, and Offices to support cross-cutting programs to advance research on the nervous system. The purpose of this Request for Information (RFI) is to seek input from the scientific community for the Blueprint to advance the fundamental understanding of neuroimmune interactions in the healthy CNS by integrative studies on dynamic interactions of non-neuronal cells and neurons.

Notice of Intent to Publish the Reissuance of PAR-18-420, NINDS Exploratory Clinical Trials (U01 - Clinical Trial Required)

NOT
Monday, April 5, 2021
Monday, January 1, 2024
NOT-NS-21-054

Funding Opportunity Purpose

The purpose of this Funding Opportunity Announcement (FOA) is to encourage grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The trials must address questions within the mission and research interests of the NINDS and may evaluate drugs, biologics, and devices, as well as surgical, behavioral and rehabilitation therapies. Information about the mission and research interests of the NINDS can be found at the NINDS website (http://www.ninds.nih.gov/)

Notice of Special Interest (NOSI): Administrative Supplements to Support Enhancement of Software Tools for Open Science

Notice of Special Interest
Monday, April 5, 2021
Sunday, May 16, 2021
333
NOT-OD-21-091

Funding Opportunity Purpose

This Notice announces the reissue of administrative supplements to active awards that focus on biomedical software development or have a significant software development component. The goal of these supplements is to invest in research software tools with recognized value in a scientific community to enhance their impact by leveraging best practices in software development and advances in cloud computing. This initiative is part of a plan for implementing the NIH Strategic Plan for Data Science which describes actions aimed at modernizing the biomedical research data ecosystem and making data findable, accessible, interoperable, and reusable (FAIR) with high impact for open science. The supplements are intended to support collaborations between biomedical scientists and software engineers to enhance the design, implementation, and cloud-readiness of research software. Through these awards, the NIH Office of Data Science Strategy (ODSS) intends to help researchers who have developed scientifically valuable software to make tools sustainable, contribute to open science, and take advantage of new data science and computing paradigms.

Pages